PN
Preston Noon
General Partner at Agent Capital
Boston, Massachusetts
Overview
Preston Noon is a General Partner and Co-Founder at Agent Capital in Boston, Massachusetts, where he focuses on investing in Series A stage companies in the pharmaceuticals and biotech sectors. With a background in pharmacy and business, he has held key roles at Baxalta, Bayer Pharmaceuticals, and Bristol-Myers Squibb, bringing a unique blend of expertise to his current position as a venture capitalist.
Work Experience
General Partner, Co-Founder
2016 - Current
A biotech venture capital firm.
Kauffman Fellow, Class 23
2018 - 2021
Co-investment VC firm supporting the mission of the Kauffman Fellows
Sr. Associate, Baxalta Ventures
2015 - 2016
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.
Post-Doctoral Associate, US Business Development & Licensing
2014 - 2015
MBA Analyst, Global Medical Affairs
2013 - 2013
Analyst, Global Recruitment Strategy & Analytics
2011 - 2013
Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Raised $23,580,000,000.00 from RA Capital Management, OUP (Osage University Partners), Aperture Venture Partners, Greg Bailey, Connecticut Innovations, Knoll Capital Management, Vivo Capital, Venrock, Litmore Capital and Carl Icahn.